Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Illustration: Sarah Grillo/Axios
Lynne Chou O'Keefe, a former partner at Kleiner Perkins, has launched a new venture capital firm called Define Ventures that will focus on early-stage digital health companies. She also raised $87 million for the firm's debut fund.
Why it matters: Digital health is a growing area, with Define to focus on such sub-sectors as telemedicine, clinical research databases, and chronic condition management.
Yes, but: Digital Health still needs to prove itself.
- Livongo Health, on whose board Chou O'Keefe spent four years before it went public last July, is now trading below its IPO stock price. So is Health Catalyst, another company that recently went public, though there are some small successes like Progyny, which bundles fertility benefits for employers and is profitable.
- Chou O'Keefe acknowledges that telemedicine isn't the panacea the tech industry thought it would be for health care—in some cases, patients need a lot of in-person interactions with their doctors.
Go deeper: Health care IPOs had a very good 2019